These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Chronic heart failure: effect and evaluation of therapy with positive inotropic substances]. Thormann J; Kramer W; Dieterich HA Herz; 1990 Jun; 15(3):190-201. PubMed ID: 2198220 [TBL] [Abstract][Full Text] [Related]
7. [Refractory heart failure. Positive inotropes and beta blockers: alternative or complementary treatments?]. Sabbadini G; Ciaccheri M; Castelli G; Sinagra G; Di Lenarda A Ital Heart J Suppl; 2002 Aug; 3(8):804-11. PubMed ID: 12407835 [TBL] [Abstract][Full Text] [Related]
8. Nonglycoside inotropes in congestive heart failure. Are they beneficial or harmful? Chatterjee K; Wolfe CL; DeMarco T Cardiol Clin; 1994 Feb; 12(1):63-72. PubMed ID: 8181026 [TBL] [Abstract][Full Text] [Related]
9. Management of congestive heart failure: is the role of positive inotropic therapy fading? Futterman LG; Lemberg L Am J Crit Care; 1996 Nov; 5(6):455-60. PubMed ID: 8922162 [TBL] [Abstract][Full Text] [Related]
10. Pharmacologic management of heart failure: positive inotropic agents. Cross JA Crit Care Nurs Clin North Am; 1993 Dec; 5(4):589-97. PubMed ID: 8297549 [TBL] [Abstract][Full Text] [Related]
12. Beta-blocking agents and positive inotropic agents in the therapy of chronic heart failure. Erdmann E; Schwinger R; Böhm M J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S138-44. PubMed ID: 11527118 [TBL] [Abstract][Full Text] [Related]
13. Calcium sensitizer agents: a new class of inotropic agents in the treatment of decompensated heart failure. Perrone SV; Kaplinsky EJ Int J Cardiol; 2005 Sep; 103(3):248-55. PubMed ID: 16098385 [TBL] [Abstract][Full Text] [Related]
14. Evolving concepts in the treatment of heart failure: should new inotropic agents carry promise or paranoia? Young JB Pharmacotherapy; 1996; 16(2 Pt 2):78S-84S. PubMed ID: 8668609 [TBL] [Abstract][Full Text] [Related]
15. The role of novel inotropic agents in the treatment of heart failure. LeJemtel TH; Keren G; Reis D; Sonnenblick EH J Cardiovasc Pharmacol; 1986; 8 Suppl 9():S47-54. PubMed ID: 2433542 [TBL] [Abstract][Full Text] [Related]
16. [New inotropic agents in the treatment of congestive heart failure]. Freitas M Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458 [TBL] [Abstract][Full Text] [Related]
17. Cardiac drugs: new inotropes. Kelleher RM Crit Care Nurs Clin North Am; 1989 Jun; 1(2):391-7. PubMed ID: 2818883 [TBL] [Abstract][Full Text] [Related]
18. Levosimendan: a new dual-action drug in the treatment of acute heart failure. Mebazaa A; Erhardt L Int J Clin Pract; 2003 Jun; 57(5):410-6. PubMed ID: 12846347 [TBL] [Abstract][Full Text] [Related]
19. [New inotropic drugs in chronic cardiac insufficiency: progress or wrong track]. Asseman P; Pruvost P; Lesenne M; Adnet P; Leroy F; Vigne JM; Delvallez L; Lacroix D; Thery C Ann Cardiol Angeiol (Paris); 1988 Mar; 37(3):153-61. PubMed ID: 3284451 [TBL] [Abstract][Full Text] [Related]
20. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure). Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D; Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]